BioCatalyst

PCRX — Pacira BioSciences, Inc. catalysts

2 verified catalyst event(s) for Pacira BioSciences, Inc. (ticker PCRX). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-11-01 — A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthri · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 1mo
ESTIMATED
 READOUT
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful O
Phase 2 · Osteoarthritis (OA) of the Knee
 PCRX Pacira BioSciences, Inc. Enekinragene Inzadenovec (PCRX-201) ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12 (month)
in 2mo
ESTIMATED
 READOUT
ZILRETTA in Subjects With Shoulder Osteoarthritis
Phase 3 · Glenohumeral Osteoarthritis
 PCRX Pacira BioSciences, Inc. ZILRETTA ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.